San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.
High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity Research, Cedars-Sinai Medical Center Reveals
High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity ResearchLos Angeles – Oct. 16, 2014 Male and female brains are not equal when it comes to the biological response to a high-fat diet. Cedars-Sinai Diabetes and…
SAN DIEGO, Oct. 23, 2014 /PRNewswire/ — MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical stage oncology drug development company, announced today a suite of online corporate communication channels to maintain on-going direct communication with shareholders and other interested parties. The Company has launched official portals on social media channels including Facebook, Twitter, LinkedIn, Google+, and The Chairman’s Blog.
The Chairman’s Blog is an online communication portal where MabVax executives will be able to address important topics as they relate to the Company’s industry and technology as well as specific points of discussion as they relate to key events at MabVax. President & CEO J. David Hansen penned the Company’s inaugural blog post “Introducing MabVax Therapeutics: Newly Public Company Achieves Multiple Milestones in Recent Quarter.” The blog post can be found online at the official MabVax Chairman’s Blog profile provided below.
“We have made significant progress on advancing our programs over the last few months and certainly plan to continue over the next year as we take important steps forward in putting three more products into the clinic,” commented Hansen.
In addition, the Company has unveiled its new website which provides investors with detailed information and an updated web design.
The website officially launched on Sept. 11, 2014 and can be found at www.mabvax.com.
Links to the new communication tools are here:
Chairman’s Blog Profile: http://www.thechairmansblog.com/author/david-hansenAbout MabVax Therapeutic Holdings, Inc.
MabVax Therapeutics, Inc., (OTCQB: MBVX) became a public company on July 8th of this year through a merger with a listed company and changed its name to MabVax Therapeutics Holdings, Inc. MabVax is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. Therapeutic vaccines under development were discovered at MSKCC and are exclusively licensed to MabVax prior to the merger. Additional information about the Company, please visit www.mabvax.com and connect with the Company on Twitter, LinkedIn, Facebook, and Google+.
Forward Looking Statements
This press release contains “forward-looking statements” regarding matters that are not historical facts, including statements relating to the effects of the merger transaction between Telik and MabVax, anticipated actions taken by the NASDAQ Panel, the potential for the Company’s shares to trade on the NASDAQ Capital Market, the Company’s expectations regarding the timing and availability of results from its clinical trials, the timing of commencement of manufacturing of the Company’s clinical trial supplies and additional clinical trials, and the safety and effectiveness of the Company’s drug, vaccine, and antibody-based therapies. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “anticipates,” “plans,” “expects,” “intends,” “will,” “potential,” “hope” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in Telik’s periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled “Risk Factors” in its annual report on Form 10-K for the fiscal year ended December 31, 2013 and in the Proxy Statement dated June 3, 2014, as supplemented on June 30, 2014, July 1, 2014 and July 3, 2014. The parties do not undertake any obligation to update forward-looking statements contained in this press release.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mabvax-therapeutics-launches-online-corporate-communication-channels-and-new-website-858506786.html
SOURCE MabVax Therapeutics Holdings, Inc.
San Diego’s Genalyte says test works on its commercially available platform.
A super-fast genome processer is now on sale by San Diego’s Edico Genome.
There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in…
[[Click headline to continue reading.]]
Connections Are Key For Independent Living Centers To Increase Employment Options For Californians With Disabilities
SACRAMENTO, Calif., Oct. 22, 2014 /PRNewswire/ – For the first time since July 2008, the nation’s unemployment rate dropped below 6 percent. While this is welcome news for many jobseekers, Californians with disabilities continue to encounter barriers to employment. Topping the list are employer bias and unreliable or non-existent transportation. California Independent Living Centers (ILCs), such as Resources for Independence Central Valley (RICV) and Disability Resource Agency for Independent Living (DRAIL), work together to eliminate these barriers by educating employers and connecting people with disabilities to agencies, programs and services that increase their employment opportunities and help them live independently.
“Connecting with employers to address their concerns, dispel misconceptions and eliminate barriers is a top priority for us,” said RICV Executive Director Robert Hand. “Many employers believe people with disabilities can’t meet job requirements or the disability will interfere with work performance. This simply isn’t true.”
RICV collaborates with others, including the Workforce Investment Board, Workability programs in Fresno and organizations in San Francisco on a Workforce Accelerator grant that addresses the requirement for federal contractors to ensure 7 percent of their workforce includes people with disabilities.
Both RICV and DRAIL also partner with the California Department of Rehabilitation (DOR), which refers individuals to ILCs approved as vendors by DOR for job preparation and placement services. The ILCs provide job coaching and training on creating resumes, strengthening interviewing skills, filling out applications, searching for jobs, setting up LinkedIn accounts and more. They continuously build new relationships with employers while making sure there’s a good “fit” between the employee and employer.
“Our approach is to tell employers to hire the best person for the job, then demonstrate why the person we’re referring is the best applicant,” Hand remarked. “The disability is irrelevant if the applicants can do the job well – only their ability is important.”
According to Ryan Moorman, DRAIL’s Job Development Coordinator, it’s critical to connect, not only with state agencies like the DOR, but also other ILCs.
“RICV helped us start our Job Development Program,” noted Moorman. “We now offer a weekly job club for individuals to share their experiences and discuss topics relevant to seeking employment. We also provide Work Incentive Planning Assistance services to help jobseekers understand how employment may affect their benefits. Through our connection with RICV, we’ve been able to exceed expectations.”
ILCs also work together when it comes to transportation barriers. People living with disabilities can be deterred from applying for jobs because of unreliable public transportation or having to depend on someone else’s schedule. Public transportation often has limited schedules and coverage and simply doesn’t exist in many rural areas. In response to these barriers, ILCs join forces to advocate for improved public transportation options and offer training on navigating transportation systems.
“Public transportation can be undependable and, many times, gets consumers to their destinations or jobs 15 to 30 minutes late,” explained Moorman. “Through education, Independent Living skills training and referrals to resources, people living with disabilities are better equipped to respond to these barriers.”
Both Hand and Moorman see the results of their efforts to address employment barriers in the success stories of individuals the ILCs have served. Moorman recalls the story of a young man whose favorite hobby was attending car shows. By listening to the young man’s needs and wants and providing job coaching and training, DRAIL found the perfect “fit” for him – a job detailing cars.
“Stories like these are gratifying,” said Moorman, “particularly, as we celebrate National Disability Employment Awareness Month in October and continue making key connections on behalf of Californians with disabilities.”
The California State Independent Living Council (SILC) is an independent state agency which, in cooperation with the California State Department of Rehabilitation, prepares and monitors the State Plan for Independent Living.
The SILC Mission: To Create Policy and System Change for Independent Living
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/connections-are-key-for-independent-living-centers-to-increase-employment-options-for-californians-with-disabilities-915070493.html
SOURCE California State Independent Living Council (SILC)
Company selling green coffee bean extract pays $3.5 million fine for touting study.
A biotech company developing an injectable drug to shrink the excess fat that forms “love handles” says it plans to raise more than $63 million through an IPO. San Diego-based Neothetics, previously…
[[Click headline to continue reading.]]
PipelineRx Announces the Availability of its Telepharmacy Information System (TPIS) Platform to the Healthcare Sector
SAN FRANCISCO, Oct. 22, 2014 /PRNewswire/ – PipelineRx, a leading medication management services company focused on clinical telepharmacy, today announced the availability of its TPIS platform offering to further address the needs of today’s efficient pharmacy. Since being announced last year, 31 hospitals are currently using the TPIS SaaS platform to bring improved clinical workflow. PipelineRx is the established leader in remote telepharmacy solutions currently partnering with over 200 hospitals to increase the quality of patient care.
PipelineRx TPIS is a SaaS based solution and is designed to provide hospitals with an extremely cost-effective remote platform that facilitates consolidation and provides cost reduction opportunities to hospitals and health systems while enabling a higher quality standard for care. This web and cloud enabled technology makes it easier for hospital pharmacies to consolidate pharmacy operations by reducing complexity of interoperability, treatment variation, and formulary deviation within a health system, all while driving clinical priorities to ensure economic viability as the market moves from a “fee for service” to a “fee for value” based reimbursement system. Unique capabilities within the PipelineRx TPIS solution provide larger hospital organizations with tools that are not found in any other solution available today.
Brian Roberts, PipelineRx’s CEO, notes that clients increasingly face complex labor and workflow challenges within the pharmacy and are looking for technology empowered solutions that streamline workflow, improve efficiency, and reduce operating costs. “PipelineRx’s software has flawlessly processed more than 5 million medication orders to date, freeing up customers to deploy key resources to improve patient care,” said Roberts. “With a flexible end-to-end solution designed by pharmacists for pharmacists, we now offer the most sophisticated unified process, from the prescription to the dispensing of medications, PipelineRx TPIS provides an ROI that is significant and immediate.”
“For 5 years we have partnered with hospitals to not only facilitate remote medication dispensing, but also evaluate and discover ways existing pharmacists can participate in the drivers of the new outcomes based economy,” said Chuck Dunlap, EVP of Customer Experience at PipelineRx. “Today’s availability of a TPIS solution brings greater flexibility to our industry, allowing better utilization of pharmacy teams and increased productivity without compromising great care.”
For more information, or to schedule an overview and demo of PipelineRx SaaS and software solutions, please contact:
EVP of Customer Experience
Next Step Communications
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pipelinerx-announces-the-availability-of-its-telepharmacy-information-system-tpis-platform-to-the-healthcare-sector-203859705.html
SAN DIEGO, CA–(Marketwired – October 21, 2014) – Highlighted Links Quidel DHI